Provided by Tiger Trade Technology Pte. Ltd.

Omeros

18.72
-0.0700-0.37%
Volume:666.51K
Turnover:12.54M
Market Cap:1.35B
PE:11.91
High:19.04
Open:18.66
Low:18.48
Close:18.79
52wk High:19.65
52wk Low:3.94
Shares:72.38M
Float Shares:67.73M
Volume Ratio:0.61
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.57
EPS(LYR):-0.0527
ROE:-576.33%
ROA:-18.68%
PB:-26.39
PE(LYR):-354.90

Loading ...

Stock Track | Omeros Plummets 5.77% Intraday Amid Mixed Analyst Opinions

Stock Track
·
May 14

Omeros Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
May 14

H.C. Wainwright Keeps Their Buy Rating on Omeros (OMER)

TIPRANKS
·
May 14

Omeros Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Stock Track | Omeros Soars 5.14% After-Hours on Strong Q1 Profit Turnaround and YARTEMLEA Launch Progress

Stock Track
·
May 14

Omeros reports Q1 adjusted EPS (24c), consensus (28c)

TIPRANKS
·
May 14

Omeros Q1 Adjusted Loss Narrows

MT Newswires Live
·
May 14

Omeros Q1 net income turns positive after YARTEMLEA launch

Reuters
·
May 14

Omeros Q1 FY26 swings to net profit of USD 56.1 million; net sales USD 9.9 million

Reuters
·
May 14

Omeros Q1 Adj. EPS $(0.24) Beats $(0.32) Estimate, Sales $9.893M Miss $10.125M Estimate

Benzinga Earnings
·
May 14

BRIEF-Omeros Corporation Q1 EPS USD 0.78

Reuters
·
May 14

Omeros Corporation Q1 Net Income USD 56.1 Million

THOMSON REUTERS
·
May 14

Omeros options imply 10.8% move in share price post-earnings

TIPRANKS
·
May 14

Press Release: Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026

Dow Jones
·
May 12

Omeros to report first-quarter results, hosts conference call after market close

Reuters
·
May 12

Omeros Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 21

Sagimet names Andreas Grauer chief medical officer as Eduardo Martins retires

Reuters
·
Apr 20

Press Release: Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

Dow Jones
·
Apr 20

Omeros says CMS assigns permanent reimbursement J-code for YARTEMLEA

TIPRANKS
·
Apr 16

CMS Assigns Permanent Reimbursement J-Code for Yartemlea® (Narsoplimab-Wuug)

THOMSON REUTERS
·
Apr 16